Dealbreaker on MSN2d
Recursion Pharma Accelerator Steps In to Fill Some of the Funding Gap Amid NIH Tumult
Altitude Lab Fund will provide pre-seed funding for early-stage startups affected by changes to grant programs administered ...
MM&M2d
Backed by Recursion CEO, Altitude Lab venture aims to fill gap from NIH cuts
Recursion CEO Chris Gibson defends the NIH, investing $1 million into a pre-seed venture to encourage critical research and ...
InnovationRx: Recursion Launches Fund For Biotech Startups Hit By NIH Funding Cuts
Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.
FierceBiotech3d
Altitude Lab sources funding, lab space for biotechs concerned about fate of NIH grants
Salt Lake City-based accelerator Altitude Lab is hoping it can entice biotechs impacted by the uncertainty surrounding federal grants.
NIH funding uncertainty spurs new biotech venture fund
Earlier this month, the Trump administration directed the National Institutes of Health (NIH) to impose limits on specific ...
Daily drug can mimic health benefits of high-altitude, low-oxygen living for mitochondrial disease
For the average person, living at high altitude—where oxygen is sparser than at sea level—can have health benefits ranging ...
Recursion CEO launches pre-seed fund in response to NIH cuts
Chris Gibson, Recursion’s head, cited the role small business grants played in helping Recursion grow its business.
Altitude Lab Startups Raise $154M in Capital
Today, Altitude Lab announced that its incubating startups have collectively raised $154 million in early-stage funding since its launch in 2020. Founded by Recursion, Altitude Lab supports diverse ...
Rocket Lab (NASDAQ:RKLB) is Soaring But Remains Below Peak Altitude
Rocket Lab USA (RKLB) has soared 473% over the past year, fueled by strong revenue growth exceeding 50% in the last three ...